Olo stock soars after Thoma Bravo agrees to acquire company for $2 billion
Under the terms of the agreement, Olo shareholders will receive $10.25 per share in cash, representing a premium of 65% over Olo's share price of $6.20 as of April 30, 2025, the last trading day before media reports about a potential deal emerged.
The transaction, unanimously approved by Olo's Board of Directors, is expected to close by the end of calendar year 2025, subject to shareholder approval and regulatory clearances. Upon completion, Olo will become a privately held company while continuing to operate under its current name and brand.
Founded in 2005, Olo provides digital ordering, payments, and guest engagement solutions to the restaurant industry. The company currently serves over 750 restaurant brands across 88,000 locations and maintains a network of more than 400 integration partners.
"By partnering with Thoma Bravo, we believe we can build on our success to date and accelerate our vision of helping our customers create a world where every restaurant guest feels like a regular," said Noah Glass, Olo's Founder and CEO.
Brandon Gardner, Chair of Olo's Board, noted that the company's strong market position enabled it to achieve a significant premium through this transaction, which the Board unanimously determined to be in the best interest of shareholders.
Goldman Sachs is serving as the exclusive financial advisor to Olo, while Goodwin Procter LLP is providing legal counsel. Kirkland & Ellis LLP is serving as legal counsel to Thoma Bravo.
Related articles
Olo stock soars after Thoma Bravo agrees to acquire company for $2 billion
BofA sees improving ad market boosting Roku's outlook as it lifts target
Morgan Stanley sees 'a compelling catalyst' for Salesforce stock rally
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a few seconds ago
- Yahoo
Canadian researchers create tool to remove anti-deepfake watermarks from AI content
OTTAWA — University of Waterloo researchers have built a tool that can quickly remove watermarks identifying content as artificially generated — and they say it proves that global efforts to combat deepfakes are most likely on the wrong track. Academia and industry have focused on watermarking as the best way to fight deepfakes and "basically abandoned all other approaches," said Andre Kassis, a PhD candidate in computer science who led the research. At a White House event in 2023, the leading AI companies — including OpenAI, Meta, Google and Amazon — pledged to implement mechanisms such as watermarking to clearly identify AI-generated content. AI companies' systems embed a watermark, which is a hidden signature or pattern that isn't visible to a person but can be identified by another system, Kassis explained. He said the research shows the use of watermarks is most likely not a viable shield against the hazards posed by AI content. "It tells us that the danger of deepfakes is something that we don't even have the tools to start tackling at this point," he said. The tool developed at the University of Waterloo, called UnMarker, follows other academic research on removing watermarks. That includes work at the University of Maryland, a collaboration between researchers at the University of California and Carnegie Mellon, and work at ETH Zürich. Kassis said his research goes further than earlier efforts and is the "first to expose a systemic vulnerability that undermines the very premise of watermarking as a defence against deepfakes." In a follow-up email statement, he said that "what sets UnMarker apart is that it requires no knowledge of the watermarking algorithm, no access to internal parameters, and no interaction with the detector at all." When tested, the tool worked more than 50 per cent of the time on different AI models, a university press release said. AI systems can be misused to create deepfakes, spread misinformation and perpetrate scams — creating a need for a reliable way to identify content as AI-generated, Kassis said. After AI tools became too advanced for AI detectors to work well, attention turned to watermarking. The idea is that if we cannot "post facto understand or detect what's real and what's not," it's possible to inject "some kind of hidden signature or some kind of hidden pattern" earlier on, when the content is created, Kassis said. The European Union's AI Act requires providers of systems that put out large quantities of synthetic content to implement techniques and methods to make AI-generated or manipulated content identifiable, such as watermarks. In Canada, a voluntary code of conduct launched by the federal government in 2023 requires those behind AI systems to develop and implement "a reliable and freely available method to detect content generated by the system, with a near-term focus on audio-visual content (e.g., watermarking)." Kassis said UnMarker can remove watermarks without knowing anything about the system that generated it, or anything about the watermark itself. "We can just apply this tool and within two minutes max, it will output an image that is visually identical to the watermark image" which can then be distributed, he said. "It kind of is ironic that there's billions that are being poured into this technology and then, just with two buttons that you press, you can just get an image that is watermark-free." Kassis said that while the major AI players are racing to implement watermarking technology, more effort should be put into finding alternative solutions. Watermarks have "been declared as the de facto standard for future defence against these systems," he said. "I guess it's a call for everyone to take a step back and then try to think about this problem again." This report by The Canadian Press was first published July 23, 2025. Anja Karadeglija, The Canadian Press Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
a few seconds ago
- Yahoo
IRS offers $2.895 million settlement with Maple Lawn over COVID-19 funding
COLDWATER, MI — County owned Maple Lawn Medical Care Facility received written confirmation Tuesday, July 22 of a settlement offer of $2.895 million from the IRS of an appeal of COVID-19 grants owed from the Employee Retention Credit program. Director Jayne Sabaitis told her board July 16 if confirmed, she would accept the offer after appealing denial of the original $3.6 million request filed three years ago during the pandemic. The money will help Maple Lawn make up for its current $1.3 million operating deficit caused by reduction in Medicaid funding for the current federal fiscal year. Prior story Maple Lawn to appeal IRS denial of $3.6 million in COVID-19 relief funds Sabaitis told her board she would consult with accountants Plante-Moran. 'We'll be discussing how that's going to affect our cost report. We want to make sure that we keep our expenses so that our Medicaid rate stays the same to make sure the use of the funds would not hurt next year's Medicaid funding," she said. Sabaitis told the board there are some capital projects which were delayed. 'We're not going to take this money and blow it. We want to hold cash as much as we can' with questions about future funding, she said. Related story With a current $1.2 million loss, Maple Lawn faces concerns with federal Medicaid cuts Sabaitis said five other Michigan nursing homes hired Washington legal counsel to sue the IRS over ERC denial. Maple Lawn was a late applicant for ERC funding only learning near the end of the pandemic the non-profit nursing facilities were eligible. The program was created for eligible businesses and tax-exempt organizations that had employees and saw increased costs or losses affected during the COVID-19 pandemic. Subscribe Support local to the Coldwater Reporter Maple Lawn is licensed for 114 beds but fluctuates by staffing. The nursing care and rehabilitation regularly reports over 90% occupancy. Contact Don Reid: dReid@ This article originally appeared on Coldwater Daily Reporter: Maple Lawn to receive $2.895 million ERC program settlement from IRS Solve the daily Crossword
Yahoo
a few seconds ago
- Yahoo
AI and Automation Integration Elevates Laboratory Informatics Demand
The North America laboratory informatics market, valued at USD 1.62 billion in 2024, is set to grow at a CAGR of 4.30% to USD 2.48 billion by 2034. Growth is fueled by cloud-based LIMS, AI, and automation. Pharma and biotech sectors leverage informatics for efficiency, boosting the market with strategic partnerships. North American Laboratory Informatics Market Dublin, July 23, 2025 (GLOBE NEWSWIRE) -- The "North America Laboratory Informatics Market Report and Forecast 2025-2034" has been added to offering. The North America laboratory informatics market was valued at USD 1.62 billion in 2024, driven by accelerating demand for cloud-based platforms. It is projected to grow at a CAGR of 4.30% from 2025 to 2034, reaching USD 2.48 billion by 2034. Informatics solutions, including LIMS, ELN, SDMS, and CDS, enhance data accuracy, compliance, and workflow automation in industries like pharmaceuticals and biotechnology. Innovations in cloud computing, AI, and automation are transforming laboratory data management by improving decision-making, regulatory compliance, and productivity. Market Growth Drivers and Trends Adoption of unified digital platforms is propelling market growth. The integration of LIMS and ELN functionalities enhances data security and collaboration. For example, eLabNext rebranded its key products into a centralised Digital Lab Platform in October 2024, aligning with market shifts toward streamlined management. The preference for advanced ELN systems is positively impacting market size. TeselaGen Biotechnology launched an enhanced ELN in December 2024, improving productivity and data management in biotech and pharmaceutical research. Global collaborations are strengthening market value. LabWare engaged with biopharma entities in Ireland in June 2024, facilitating knowledge exchange and technological advancements in LIMS adoption. Integration of AI and Automation The demand for AI-driven automation is elevating market demand. Funding initiatives support development in automated chemical laboratories, accelerating innovation and efficiency. By reducing manual errors, AI integrations boost LIMS and ELN system adoption, driving long-term market growth. Emerging Trends Cloud-Based LIMS: With significant IT sector contributions to GDP, cloud solutions are becoming essential for efficiency and compliance. Partnerships such as Revvity Signals Software with Scitara drive innovations in cloud-based platforms for R&D. AI and Automation: Initiatives like Scialog and LabVantage Solutions' integration of mixed reality demonstrate a shift towards AI-driven laboratory processes, enhancing efficiency and research competitiveness. Strategic Partnerships: Collaborations, such as those by LabVantage, are fuelling regulatory compliance and workflow automation, offering growth opportunities in laboratory informatics. Market Segmentation and Key Players: The market is segmented by product, delivery mode, component, end user, and region, with LIMS leading due to its pivotal role in sample management and workflow automation. Cloud solutions are preferred for scalability, while software advancements drive component value. Pharmaceutical companies hold the largest share, driven by stringent regulatory demands and R&D investments. Their adoption of informatics solutions enhances drug development and compliance. Major companies include Serum Institute of India, CSL Limited, Bharat Biotech, and CanSino Biologics, further shaping market dynamics with innovative solutions and global strategies. Region Analysis The United States dominates the market with strong R&D investments and digitalisation, while Canada shows growth due to government initiatives and cloud platform adoption. Both countries advance laboratory informatics with investments in data management and AI solutions. Conclusion The North America laboratory informatics market continues to grow, driven by technological advancements and strategic initiatives. The emphasis on AI, automation, and cloud solutions fosters efficiency and competition in the biotech, pharmaceutical, and research sectors. Key Attributes: Report Attribute Details No. of Pages 300 Forecast Period 2025 - 2034 Estimated Market Value (USD) in 2025 $1.62 Billion Forecasted Market Value (USD) by 2034 $2.48 Billion Compound Annual Growth Rate 4.3% Regions Covered North America For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment North American Laboratory Informatics Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
